Pacer Advisors Inc. grew its position in shares of Exelon Co. (NASDAQ:EXC - Free Report) by 36.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 168,897 shares of the company's stock after buying an additional 45,359 shares during the quarter. Pacer Advisors Inc.'s holdings in Exelon were worth $6,357,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently modified their holdings of the company. State Street Corp raised its position in shares of Exelon by 3.7% during the third quarter. State Street Corp now owns 60,169,219 shares of the company's stock worth $2,439,862,000 after acquiring an additional 2,156,259 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Exelon by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 25,945,791 shares of the company's stock valued at $1,048,823,000 after acquiring an additional 403,542 shares during the last quarter. FMR LLC boosted its position in shares of Exelon by 18.7% in the 3rd quarter. FMR LLC now owns 11,782,549 shares of the company's stock worth $477,782,000 after purchasing an additional 1,858,502 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Exelon by 1.8% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,967,343 shares of the company's stock worth $363,626,000 after purchasing an additional 160,313 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its holdings in Exelon by 2.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 6,446,408 shares of the company's stock valued at $261,402,000 after purchasing an additional 123,466 shares during the last quarter. Institutional investors own 80.92% of the company's stock.
Exelon Stock Up 1.1 %
Shares of NASDAQ EXC traded up $0.45 during mid-day trading on Thursday, reaching $40.02. 5,754,331 shares of the company's stock traded hands, compared to its average volume of 6,418,678. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.09 and a quick ratio of 0.97. The business has a 50-day simple moving average of $38.18 and a 200 day simple moving average of $38.49. The stock has a market cap of $40.21 billion, a P/E ratio of 16.47, a PEG ratio of 2.61 and a beta of 0.55. Exelon Co. has a 1-year low of $33.35 and a 1-year high of $41.19.
Exelon (NASDAQ:EXC - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.71 earnings per share for the quarter, topping the consensus estimate of $0.67 by $0.04. The business had revenue of $6.15 billion for the quarter, compared to analysts' expectations of $5.85 billion. Exelon had a net margin of 10.60% and a return on equity of 9.47%. The firm's revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period in the previous year, the company earned $0.67 earnings per share. On average, analysts expect that Exelon Co. will post 2.46 EPS for the current fiscal year.
Analysts Set New Price Targets
Several research analysts recently commented on the company. Barclays reduced their price target on Exelon from $44.00 to $42.00 and set an "overweight" rating for the company in a research report on Wednesday, January 22nd. Evercore ISI upgraded shares of Exelon from an "in-line" rating to an "outperform" rating and boosted their price objective for the stock from $43.00 to $44.00 in a research note on Tuesday, January 21st. Guggenheim upgraded shares of Exelon from a "neutral" rating to a "buy" rating in a research note on Thursday, January 23rd. Scotiabank boosted their price target on Exelon from $40.00 to $42.00 and gave the stock a "sector perform" rating in a research report on Thursday, December 12th. Finally, Morgan Stanley cut their price objective on Exelon from $46.00 to $44.00 and set an "equal weight" rating for the company in a research report on Friday, November 22nd. Five equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $43.13.
Get Our Latest Stock Analysis on EXC
Exelon Profile
(
Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
See Also
Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.